ELI LILLY & Co Logo

ELI LILLY & Co

Pharma leader developing medicines for diabetes, obesity, oncology, and neuroscience.

LLY | US

Overview

Corporate Details

ISIN(s):
US5324571083
LEI:
Country:
United States of America
Address:
LILLY CORPORATE CTR, 46285 INDIANAPOLIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Eli Lilly and Company is a global pharmaceutical corporation engaged in the discovery, development, manufacturing, and commercialization of human healthcare products. Founded in 1876, the company has a long history of medical innovation, focusing on creating medicines for significant health challenges. Its portfolio primarily targets non-communicable diseases, with key therapeutic areas including diabetes, oncology, immunology, and neuroscience. Lilly is widely recognized for its pioneering role in diabetes care and has more recently become a prominent leader in the development of novel therapies for obesity and related metabolic conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ELI LILLY & Co filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ELI LILLY & Co

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ELI LILLY & Co via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Oric Pharmaceuticals, Inc. Logo
Developing therapies to overcome resistance in lung and prostate cancer.
United States of America ORIC
Orion Oyj Logo
Develops and manufactures human/vet pharma, APIs, and generics for global markets.
Finland ORNAV
Oruka Therapeutics, Inc. Logo
Develops long-acting antibody therapies for chronic inflammatory and skin diseases.
United States of America ORKA
Orum Therapeutics, Inc. Logo
Developing degrader-antibody conjugates for cell-selective protein degradation to treat cancer.
South Korea 475830
OSR Holdings, Inc. Logo
Acquires biopharma R&D platforms to build a diverse portfolio of healthcare therapies.
United States of America OSRH
OS Therapies Inc Logo
Developing a cancer vaccine to treat HER2-expressing tumors, primarily Osteosarcoma.
United States of America OSTX
Otsuka Holdings Co., Ltd. Logo
Global healthcare group creating pharmaceuticals and nutraceuticals for worldwide well-being.
Japan 4578
Outlook Therapeutics, Inc. Logo
Developing an ophthalmic bevacizumab to treat retinal diseases like wet AMD.
United States of America OTLK
Ovid Therapeutics Inc. Logo
Developing targeted small molecule therapies for rare neurological diseases and epilepsies.
United States of America OVID
Ovoca Bio Plc Logo
Biopharma developing a novel therapy for premenopausal women with low sexual desire (HSDD).
Ireland OVXA

Talk to a Data Expert

Have a question? We'll get back to you promptly.